Matches in Nanopublications for { ?s ?p "[Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP323956.RAzpUMG75wcwugKh-jfmndilY0VxJ87fcIUhpwsdpM6tI130_assertion description "[Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323956.RAzpUMG75wcwugKh-jfmndilY0VxJ87fcIUhpwsdpM6tI130_provenance.
- assertion description "[Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP300861.RAUE9FfGThSwVeomGH6OEzVGYbXFTly6DZ_R88nLjtbkA130_assertion description "[Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300861.RAUE9FfGThSwVeomGH6OEzVGYbXFTly6DZ_R88nLjtbkA130_provenance.
- NP1363095.RAFtqDQ8sHPT4wyiNv0ojez58caR30OaSmXr7jiDigZ3M130_assertion description "[Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1363095.RAFtqDQ8sHPT4wyiNv0ojez58caR30OaSmXr7jiDigZ3M130_provenance.
- NP1363098.RA-PTTf5sM1ofsUNkxQmWniM7SfsfMfz-so3HCiI14Gjs130_assertion description "[Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1363098.RA-PTTf5sM1ofsUNkxQmWniM7SfsfMfz-so3HCiI14Gjs130_provenance.